Clinical development arm of the Japanese pharmaceutical company Kyowa Kirin, operating from sites in the United States and the United Kingdom to run the group's global clinical trials. Handles clinical study design and management, biostatistics and data management, clinical pharmacology, pharmacovigilance, medical affairs and regulatory submissions for the group's nephrology, oncology, immunology and rare disease programmes.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen